• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. FLUENCY PLUS ENDOVASCULAR STENT GRAFT; ENDOVASCULAR STENT GRAFTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. FLUENCY PLUS ENDOVASCULAR STENT GRAFT; ENDOVASCULAR STENT GRAFTS Back to Search Results
Model Number FEM10060
Device Problems Positioning Failure (1158); Material Perforation (2205)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
The lot number for the device was provided.The device history records are currently under review.The device has been returned for evaluation.The investigation is currently underway.
 
Event Description
It was reported that during a stent graft placement procedure the stent graft allegedly failed to deploy from the delivery system.There was no reported patient injury.
 
Manufacturer Narrative
Manufacturing review: manufacturing record review was not performed, as the information available does not reasonably suggest a manufacturing process may have caused or contributed to the reported event.Investigation summary: a stent graft delivery system was returned.Based on the evaluation of the returned sample the reported issue was confirmed.The stent graft was found not deployed and a strut of the stent graft was found perforating the distal end of the outer sheath, which made stent graft deployment impossible.No indication was found for manufacturing related issues.As a result of the investigation performed the complaint is confirmed.A definite root cause for the reported event could not be determined.Labeling review: in reviewing the current labeling supplied with this product it was found that the instructions for use (ifu) sufficiently address the potential risks.Regarding preparation of the device the ifu states that "prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline (.).Flushing these lumens will also facilitate stent graft deployment." regarding the anatomy of the placement site the ifu states: "prior to stent graft deployment (.), ensure that the proximal stent graft end is positioned in a straight section of the lumen to reduce the risk of increased deployment forces and possible failure to deploy." additional narrative: date received by mfr.Corrected data: device evaluated by mfr, evaluation codes (results, conclusion).
 
Event Description
It was reported that during a stent graft placement procedure the stent graft allegedly failed to deploy from the delivery system.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS ENDOVASCULAR STENT GRAFT
Type of Device
ENDOVASCULAR STENT GRAFTS
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key8624607
MDR Text Key145535828
Report Number2020394-2019-00581
Device Sequence Number1
Product Code PFV
UDI-Device Identifier04049519008592
UDI-Public(01)04049519008592
Combination Product (y/n)N
PMA/PMN Number
P130029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 05/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/02/2021
Device Model NumberFEM10060
Device Catalogue NumberFEM10060
Device Lot NumberANCY0390
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/24/2019
Initial Date Manufacturer Received 04/24/2019
Initial Date FDA Received05/20/2019
Supplement Dates Manufacturer Received05/22/2019
Supplement Dates FDA Received05/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-